Suppr超能文献

心脏手术后术中输红细胞与死亡率。

Intra-operative red blood cell transfusion and mortality after cardiac surgery.

机构信息

Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Koekoekslaan 1, 3430 EM, Nieuwegein, The Netherlands.

Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.

出版信息

BMC Anesthesiol. 2019 May 4;19(1):65. doi: 10.1186/s12871-019-0738-2.

Abstract

BACKGROUND

Anemia in cardiac surgery patients has been associated with poor outcomes. Transfusion of red blood cells during surgery is common practice for perioperative anemia, but may come with risks. Little is known about the association between intra-operative transfusion and mortality in patients undergoing cardiac surgery.

METHODS

Single centre historical cohort study in 2933 adult patients undergoing coronary surgery with or without aortic valve replacement from June 2011 until September 2014. To estimate the odds ratio for mortality in patients receiving intra-operative transfusion, a propensity score based logistic regression analysis was performed.

RESULTS

Intra-operative transfusion was associated with a more than three-fold increased risk of 30-day mortality. Patients in the highest quartile of probability of transfusion were older (age 75 vs 66; P <  0.001), had a higher EuroSCORE (6 vs 3; P <  0.001), had lower preoperative hemoglobin levels (7.6 vs 8.9 mmol/l; P < 0.001), had combined surgery more often (CABG + AVR in 33.4% of cases vs 6.6% (P < 0.001) and a longer duration of surgery (224 vs 188 min; P < 0.001). The association between intra-operative transfusion and mortality persisted after adjustment for these risk factors (adjusted OR 2.6; P = 0.007).

CONCLUSIONS

Intra-operative transfusion of red blood cells was found to be associated with increased mortality in adults undergoing coronary surgery. Preoperative patient optimization may improve perioperative outcomes by reducing the likelihood of requiring transfusion and thus its associated risk.

摘要

背景

心脏手术患者的贫血与不良结局有关。手术期间输注红细胞是围手术期贫血的常见做法,但可能存在风险。对于接受心脏手术的患者,术中输血与死亡率之间的关系知之甚少。

方法

这是一项 2011 年 6 月至 2014 年 9 月期间进行的 2933 例成人冠状动脉手术(伴或不伴主动脉瓣置换术)的单中心历史队列研究。为了评估接受术中输血的患者的死亡率的比值比,进行了基于倾向评分的逻辑回归分析。

结果

术中输血与 30 天死亡率增加三倍以上相关。输血概率最高四分位数的患者年龄更大(75 岁比 66 岁;P < 0.001),EuroSCORE 更高(6 分比 3 分;P < 0.001),术前血红蛋白水平更低(7.6 比 8.9 mmol/L;P < 0.001),更常进行联合手术(CABG+AVR 在 33.4%的病例中,而 6.6%(P < 0.001),手术时间更长(224 比 188 分钟;P < 0.001)。在校正这些危险因素后,术中输血与死亡率之间的关联仍然存在(校正比值比 2.6;P = 0.007)。

结论

在接受冠状动脉手术的成年人中,输注红细胞与死亡率增加相关。术前患者优化可能通过降低需要输血的可能性及其相关风险来改善围手术期结局。

相似文献

引用本文的文献

7
Sex-specific disparities in patients undergoing isolated CABG.接受单纯冠状动脉旁路移植术患者的性别差异。
Am Heart J Plus. 2023 Oct 19;35:100334. doi: 10.1016/j.ahjo.2023.100334. eCollection 2023 Nov.
10
Postoperative anemia in cardiac surgery patients: a narrative review.心脏手术患者术后贫血:一项叙述性综述。
Can J Anaesth. 2024 Mar;71(3):408-421. doi: 10.1007/s12630-023-02650-9. Epub 2023 Nov 28.

本文引用的文献

4
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.心脏手术中红细胞的限制输血或自由输血。
N Engl J Med. 2017 Nov 30;377(22):2133-2144. doi: 10.1056/NEJMoa1711818. Epub 2017 Nov 12.
10
Effect of patient age on blood product transfusion after cardiac surgery.患者年龄对心脏手术后输血的影响。
J Thorac Cardiovasc Surg. 2015 Jul;150(1):209-14. doi: 10.1016/j.jtcvs.2015.03.022. Epub 2015 Mar 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验